Early recombinant human growth hormone treatment improves mental development and alleviates deterioration of motor function in infants and young children with Prader-Willi syndrome.

World J Pediatr · 2023 · PMC10149441 · PMID 36564648

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

In one study, rhGH treatment in infants and toddlers aged 4–37 months resulted in a positive trend of mobility and stability when assessed using TIME [ 6 ].

also in 6,846 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.